Parathyroid hormone-eluting bead - CellMed
Alternative Names: CellBead-PTH; PTH-eluting beadLatest Information Update: 02 Oct 2021
At a glance
- Originator CellMed
- Class Calcium regulators; Osteoporosis therapies; Peptide hormones; Recombinant proteins
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypoparathyroidism
Most Recent Events
- 10 Aug 2007 Discontinued - Phase-II for Hypoparathyroidism in Germany (Intralesional)
- 15 Nov 2005 Phase-II clinical trials in Hypoparathyroidism in Germany (Intralesional)